The FDA continues to recommend against ivermectin for treating or preventing COVID-19, despite claims to the contrary
There have been many misleading claims about ivermectin’s effectiveness as a COVID-19 treatment. While recognized for its efficacy against parasites, ivermectin’s antiviral effects remain uncertain, and clinical trials have not shown conclusive benefits for COVID-19. Health authorities caution against its use for COVID-19 due to potential side effects and a lack of reliable supporting evidence. The U.S. Food and Drug Administration hasn’t changed its stance, contrary to recent social media posts incorrectly claiming otherwise. The agency maintains its position that ivermectin is not approved for COVID-19 prevention or treatment.